Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:

NCT ID: NCT05970146 Recruiting - Clinical trials for Complex Regional Pain Syndromes

Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome

Start date: August 1, 2023
Phase: Phase 4
Study type: Interventional

Evaluate the efficacy of two regimens of management in relieving chronic refractory pain in patients with upper limb complex regional pain syndrome after orthopedic trauma

NCT ID: NCT05952011 Recruiting - Anesthesia Clinical Trials

Effect of Stellate Ganglion Block on Internal Mammary Artery Dynamics

Start date: August 8, 2023
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the diameter of Left internal mammary artery and its blood flow by using the pulsatility index before and after the left stellate ganglion block in patients undergoing coronary artery bypass grafting.

NCT ID: NCT05932485 Recruiting - Clinical trials for Stellate Ganglion Block

Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Post-operative new-onset atrial fibrillation (POAF) is one of the most common arrhythmias in adults after direct intracardiac surgery with extracorporeal circulation. The incidence of POAF in coronary artery bypass grafting (CABG) is approximately 30%. POAF can lead to an increased risk of complications such as stroke, heart failure, and acute kidney injury, which not only prolongs the patient's hospital stay, but also increases hospital costs and mortality. operation, extracorporeal circulation, and the patient's underlying conditions (such as age, gender, hypertension, and diabetes), which cause sympathetic activation, inflammatory response, and myocardial ischemia in the organism. The stellate ganglion block (SGB) regulates the sympathetic tone of the innervated nerves and thus the autonomic function of the body. SGB can effectively regulate the sympathetic-parasympathetic imbalance. Also, SGB may exert some anti-inflammatory effects. In this study, ultrasound-guided SGB was used in CABG patients to investigate its effect on the occurrence of POAF.

NCT ID: NCT05854537 Completed - Postoperative Pain Clinical Trials

Sphenopalatine Ganglion Block in Maxillofacial Surgeries

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

Patients will be divided into 2 groups, 30 each. Group A will receive sphenopalatine ganglion block via a gauze soaked in local anesthetic introduced in the 2 nostrils then by local anesthetic injected by a cannula into both nostrils. Group B will undergo the same procedure, but normal saline will be used instead of the local anesthetic.

NCT ID: NCT05771103 Recruiting - Clinical trials for Post-mastectomy Pain Syndrome

Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

- Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy. - Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance

NCT ID: NCT05720936 Recruiting - Arrhythmic Storm Clinical Trials

In-hospital Stellate Ganglion Block for Arrhythmic Storm

STAR
Start date: January 2017
Phase:
Study type: Observational [Patient Registry]

Arrhythmic storm is a real emergency and its treatment could be challenging. Antiarrhythmic drugs are few and often ineffective. Neuromodulation has been grown in evidences but no large multicentric studies are present in literature about safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB). Patients with an electrical storm refractory to at least one antiarrhythmic drug will receive PSGB and will be enrolled in the present study. The number of defibrillations before and after the treatment will be compared, complications will be annotated.

NCT ID: NCT05707754 Recruiting - Clinical trials for Sphenopalatine Ganglion Nerve Block

Sphenopalatine Ganglion Block Study

Start date: March 6, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to compare the administration and dosage of bupivacaine for sphenopalatine ganglion (SPG) nerve block. The main question[s] it aims to answer are: - Does a high dose (3ml) give more relief than a low dose (1ml)? - Does bilateral administration give more relief than unilateral? Participants with headaches will be asked to lie down and have SPG block performed. Researchers will compare dosage and administration to see how symptoms are reduced.

NCT ID: NCT05664711 Active, not recruiting - Clinical trials for Chronic Fatigue Syndrome

Effect of Stellate Ganglion Block on ME/CFS

SGB_ME
Start date: March 15, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to study the effects of stellate ganglion block (SGB) in participants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The main questions it aims to answer are: Does SGB treatment improve symptoms of ME/CFS (e.g. brain fog, fatigue)? Do changes in symptoms go along with changes in blood or saliva? Participants will receive a total of six blocks over three weeks (one block on each side, one day apart, per week). Prior to treatment and at two points following treatment, participants will complete surveys, take a cognitive (puzzle type) test, and provide blood and saliva for analysis. Participants will measure their heart rate daily using a free smart phone app.

NCT ID: NCT05652179 Completed - Clinical trials for Stellate Ganglion Block

SGB Reduces the Incidence and Severity of CSA-AKI

Start date: January 10, 2023
Phase: N/A
Study type: Interventional

The incidence of acute kidney injury after cardiopulmonary bypass cardiac surgery is high, which increases postoperative mortality and is not conducive to the prognosis of patients. Stellate ganglion blocks increase renal blood flow, reduce inflammation and stress, and protect the heart muscle. In this study, stellate ganglion block was used to promote rapid recovery of kidney function after cardiopulmonary bypass cardiac surgery.

NCT ID: NCT05627895 Completed - Clinical trials for Basal-ganglia fMRI Neurofeedback

Brain Self-regulation for Parkinson's

Brain-REG
Start date: August 17, 2023
Phase:
Study type: Observational

To investigate feasibility of basal-ganglia regions as fMRI-neurofeedback targets in Parkinson's patients and evaluate self-regulation success